News

Drug Delivery Business2d
Tandem agrees to pay $36M to settle Roche patent litigation
Tandem Diabetes Care (Nasdaq:TNDM) recently filed an SEC Form 8-K announcing its entry into a patent litigation settlement ...
Drug Delivery Business2d
Modular Medical adds insulin delivery tech veteran to board
Modular Medical (Nasdaq:MODD) announced that it appointed industry veteran Jeff Goldberg to its board of directors.
Drug Delivery Business9d
Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...
Drug Delivery Business11d
Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery ...
Drug Delivery Business8d
Embecta eyes shift from insulin delivery to broader medical supplies focus
Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...
Drug Delivery Business10d
Medtronic to separate Diabetes business unit
Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.
Drug Delivery Business9d
Senseonics closes public offering, private placement with Abbott
Senseonics (NYSE:SENS) announced that it closed its previously announced public offering and private placement with Abbott.
drugdeliverybusiness12d
Glooko adds chief strategy officer to chief medical officer’s title
Glooko announced today that it expanded the position of Dr. Mark Clements to make him its chief medical and strategy officer. Clements became the Palo Alto, California-based diabetes management ...